TIBS partners with National Health Innovation Centre Singapore to nurture promising biotech projects across public healthcare clusters in Singapore
17th October 2022, TIBS entered into a partnership with the National Health Innovation Centre Singapore (NHIC, https://nhic.sg/) to co-create biotech start-ups arising from home-grown, cost-effective technologies. TIBS will collaborate with NHIC to enhance its capability of turning locally developed cutting-edge biotechnologies into innovative therapeutics to address global unmet medical needs.
Through this partnership, TIBS will be able to access and assist the pool of innovative health-tech solutions developed by Singapore’s public healthcare institutions, medical schools, institutions of higher learning and research institutions, and collaborate with Singapore’s advanced clinical trials support ecosystem.
Prof Tina Wong, Executive Director, NHIC (left) inked the CADRE2 partnership with Mr Langdon Wu, General Manager, TIBS (right) on 17 October 2022. The ceremony was witnessed by Dr Cheong Wei Yang, Deputy Secretary (Technology), Ministry of Health (centre). Photo courtesy of the Consortium for Clinical Research and Innovation, Singapore (CRIS).
Together with NHIC the collaboration in Clinical Advancement and Development for Research, Entrepreneurship and Enterprise (CADRE2) play to the strengths of the public and private sectors; NHIC would identify and support the achievement of healthcare objectives, while TIBS would introduce the commercial discipline that prepares the projects to create innovations that are market-ready and investable.
“This is a milestone for TIBS. We are thrilled to collaborate with NHIC and local clinicians. As an investor, we will continue to help passionate researchers and entrepreneurs develop corporate venture aiming to transform biomedical innovations into cures for humanity.” - Jack Yin PhD, Founding Partner & Chairman, TIBS.
About the National Health Innovation Centre Singapore (NHIC)
The National Health Innovation Centre Singapore (NHIC), is a nationally-appointed Innovation and Enterprise Office that works with Public Health Institutions across Singapore to identify and commercialise promising clinical innovations. The NHIC funds the translation and development of medical innovations from Singapore’s clinical sector, and provide strategic guidance and connection to industry partners, accelerating the pathway to impact in healthcare. Established since 2014, NHIC has supported many projects and companies in the development and implementation of innovative medical technologies and services, improving the standard of healthcare in Singapore and beyond. NHIC is part of the Consortium for Clinical Research and Innovation Singapore (CRIS).